
BRO Stock Forecast & Price Target
BRO Analyst Ratings
Bulls say
Brown & Brown is supported by a diversified, relationship-driven platform that should keep revenue durable even if organic growth is near the bottom end of peers in 2026. Its Retail franchise serves a highly diversified client base with more than 1,000 carrier partners, while Specialty Distribution and contingent commissions provide added growth levers; management also expects 2026 contingents to rise to $255M and sees strong cash flow conversion. Despite some near-term competition in cat-exposed property and pharmacy pricing pressure, the company has posted top-tier margins, with adjusted EBITDAC improving to 36% from 33% from 2023 to 2025, and its AI and acquisition synergies should support earnings quality.
Bears say
Brown & Brown is facing a negative setup because its commission-heavy model is highly exposed to softer premium rates, and property CAT pricing has already fallen 15%-35% in recent quarters, threatening organic growth, revenue, and margins. Management has also signaled only modest organic improvement, with 1Q26 up 23% YoY cash generation to $262M offset by slower M&A, just 8 deals totaling $9M of annual revenue, and capital prioritized toward buybacks and debt paydown rather than aggressive expansion. Competitive pressure from larger peers moving into the middle market, plus a likely slower economic backdrop and execution risk around acquisitions, further weakens the firm’s ability to sustain above-peer growth.
This aggregate rating is based on analysts' research of Brown & Brown and is not a guaranteed prediction by Public.com or investment advice.
BRO Analyst Forecast & Price Prediction
Start investing in BRO
Order type
Buy in
Order amount
Est. shares
0 shares